compare_entities
Exposed by 1313 servers, with 2 different definitions behind the one name.
The same name does not mean the same tool here.
1313 servers expose compare_entities and we have recorded 2 distinct definitions of it. Compare the parameters below before assuming one is a drop-in for another.
Recreation.gov MCP — wraps the Recreation Information Database (RIDB) API v1
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Reddit MCP — public Reddit data via JSON endpoints (no auth required)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Regrid MCP — wraps the Regrid Parcel API v2 (regrid.com)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Regulations.gov MCP — federal regulatory dockets, documents, public comments
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Regulatory Catalysts MCP — high-value biotech regulatory calendar events (keyless).
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
RemoteOK MCP — remote-work job board (tech-heavy), keyless.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Remotive MCP — curated remote-only job board
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Rentcast MCP — wraps Rentcast API (api.rentcast.io/v1)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Repology cross-distro package version aggregator
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Retractions / research-integrity MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Revternal MCP — wraps the Revternal Developer Intelligence API
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
RFC Editor MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Rhea MCP — expert-curated database of biochemical reactions.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Rick and Morty MCP — wraps the Rick and Morty API (free, no auth)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Rick and Morty MCP — wraps The Rick and Morty API (free, no auth)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Rijksmuseum MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Sveriges Riksbank (Sweden's central bank) SWEA v1 MCP. Keyless.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Riksdagen (Swedish Parliament) open data MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Riot Games API MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
RIPE Stat MCP — IP/ASN/BGP data
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
What this page is
Every field above is reproduced as the server published it at the time shown. The description and the annotations are claims by the server's author. Toolpin does not call tools, so we cannot tell you whether a tool does what it says.
What we can tell you is whether the claim changed. The hash covers the fields the MCP specification defines, so a vendor build stamp does not move it but a rewritten description does. See how we monitor, or this server's change history.